How is the Celularity Inc - Ordinary Shares - Class A today?

The Celularity Inc - Ordinary Shares - Class A today is trading in the down by -0.57% at 1.75.

How has Celularity Inc - Ordinary Shares - Class A performed historically?

The Celularity Inc - Ordinary Shares - Class A is currently trading down -0.57% on an intraday basis in the past week the index fell -15.87%. The index has been up 12.90% in the past quarter and fell -45.31% in the past year. You can view this in the overview section.

What is Celularity Inc - Ordinary Shares - Class A Annual Revenue?

Celularity Inc - Ordinary Shares - Class A Annual Revenue rose 138.11%, in the last year to $54.22 M. Its sector's average revenue growth for the last fiscal year was 1.87%.

What is Celularity Inc - Ordinary Shares - Class A Annual Net Profit?

Celularity Inc - Ordinary Shares - Class A Annual Net Profit rose 70.51% in the last year to $57.89 M. Its sector's average net profit growth for the last fiscal year was -12.56%.

What is Celularity Inc - Ordinary Shares - Class A Price to Earning Ratio?

Celularity Inc - Ordinary Shares - Class A Price to Earning Ratio is -0.72, which is negative.

What is Celularity Inc - Ordinary Shares - Class A Stock Price?

Celularity Inc - Ordinary Shares - Class A Stock Price fell 45.31% and underperformed its sector by 68.27% in the past year.

What is Celularity Inc - Ordinary Shares - Class A Quarterly Revenue?

Celularity Inc - Ordinary Shares - Class A Quarterly Revenue rose 49.7% YoY to $18.13 M. Its sector's average revenue growth YoY for the quarter was 4.33%.

What is Celularity Inc - Ordinary Shares - Class A Quarterly Net profit?

Celularity Inc - Ordinary Shares - Class A Quarterly Net profit fell 239.24% YoY to $13.29 M. Its sector's average net profit growth YoY for the quarter was 10.15%.

What is Celularity Inc - Ordinary Shares - Class A Debt to Equity Ratio?

Celularity Inc - Ordinary Shares - Class A Debt to Equity Ratio of 7.79 is higher than 1. This implies that company assets are financed through debt.

What is Celularity Inc - Ordinary Shares - Class A Return on Equity(ROE)?

Celularity Inc - Ordinary Shares - Class A Return on Equity(ROE) for the last financial year was -232.51%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Celularity Inc - Ordinary Shares - Class A Mutual Fund Holding?

Celularity Inc - Ordinary Shares - Class A Mutual Fund Holding decreased by 0.04% in the last quarter to 3.78.

What is Celularity Inc - Ordinary Shares - Class A Interest Coverage Ratio?

Celularity Inc - Ordinary Shares - Class A Interest Coverage Ratio is -8.24, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Celularity Inc - Ordinary Shares - Class A Institutional Holding?

Celularity Inc - Ordinary Shares - Class A Institutional Holding increased by 0.18% in the last quarter to 14.96.

MARKETS
SECTOR : COMMERCIAL SERVICES & SUPPLIES
INDUSTRY : MISCELLANEOUS COMMERCIAL SERVICES
CELULARITY INC - ORDINARY SHARES - CLASS A

Celularity Inc - Ordinary Shares - Class A XNAS: CELU

Celularity Inc - Ordinary Shares - Class A Live Share Price Today, Share Analysis and Chart

Name: Celularity Inc - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Celularity Inc - Ordinary Shares - Class A
Rating: 1.15800
Author: Trendlyne DVM scores

about

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adher...

1.75 -0.01 (-0.57%)

66.48% Fall from 52W High

18,652

XNAS Volume

XNAS 13 Jun, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

14.5 / 100

Technically Bearish

31.8 / 100

No estimates available

Celularity Inc - Ordinary ... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Celularity Inc - Ordinary Shares - Class A Live Share Price Today, Share Analysis and Chart

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adher...

66.48% Fall from 52W High

SWOT Analysis

Celularity Inc - Ordinary ... Live Price Chart

Celularity Inc - Ordinary Shares - Class A FAQ

How is Celularity Inc - Ordinary Shares - Class A today?

Celularity Inc - Ordinary Shares - Class A today is trading in the red, and is down by -0.57% at 1.75.

How has Celularity Inc - Ordinary Shares - Class A performed historically?

Celularity Inc - Ordinary Shares - Class A is currently trading down -0.57% on an intraday basis. In the past week the stock fell -15.87%. stock has been up 12.90% in the past quarter and fell -45.31% in the past year. You can view this in the overview section.